CDC20 and prostate carcinoma: In order to confirm that the methyltransferase activity of KMT5A is important for the regulation of CDC20 expression in prostate cancer cell lines we used two molecules that have shown inhibitory activity against KMT5A, namely UNC0379 and Ryuvidine [40,41] (Supplementary Figure S2).